NCT04104295 is a NA clinical trial of Ultrasound following X-ray in Nasogastric Tube, sponsored by Yale University.

Who is sponsoring NCT04104295?

NCT04104295 is sponsored by Yale University.

What drugs are being tested in NCT04104295?

Interventions in NCT04104295: Ultrasound following X-ray.

What condition does NCT04104295 study?

NCT04104295 studies Nasogastric Tube.

Is NCT04104295 still recruiting?

NCT04104295 is currently withdrawn. Last updated 20 April 2021.

Last reviewed 2021-04-20 · How we verify

NCT04104295

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Use of Ultrasound in Nasogastric Tube Placement in Children Admitted to the Pediatric ICU

Withdrawn NA Last updated 20 April 2021

What this trial tests

NA trial testing Ultrasound following X-ray in Nasogastric Tube. Withdrawn.

Timeline

24 March 2020

Primary endpoint
30 September 2020

31 January 2021

Quick facts

Lead sponsor	Yale University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Start date	24 March 2020
Primary completion	30 September 2020
Estimated completion	31 January 2021

Drugs / interventions tested

Ultrasound following X-ray

Conditions studied

Nasogastric Tube — all drugs for Nasogastric Tube →

Sponsor

Yale University

Who can join

Adults 0 to 18, any sex, with Nasogastric Tube. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if ultrasound (US), when used by the clinician, can determine the presence of nasogastric tube (NGT) in the stomach of patients admitted to the pediatric intensive care unit (PICU).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Ultrasonography for confirmation of gastric tube placement.
Tsujimoto Y, Kataoka Y, Banno M, Anan K, et al · · 2024 · cited 3× · PMID 39051488 · DOI 10.1002/14651858.cd012083.pub3

Verify or expand the search:

Other recruiting trials for Nasogastric Tube

Currently open trials in the same condition.

NCT06262815 — The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction · active not recruiting

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04104295 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 20 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04104295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing